 The goal of this clinical research study is to learn if erlotinib hydrochloride Tarcevaâ OSI-774 can prevent cancer in the mouth of people with a high risk of developing cancer in the mouth. The safety of this drug will also be studied, as well as the drugs effect on different cells in the body. 